Grant Details
| Grant Number: |
5R01CA064247-04 Interpret this number |
| Primary Investigator: |
Ho, Gloria |
| Organization: |
Albert Einstein Col Of Med Yeshiva Univ |
| Project Title: |
Spontaneous Regression Biomarkers in Cervix Dysplasia |
| Fiscal Year: |
1998 |
Abstract
Cervix intraepithelial neoplasia (CIN), a precancerous lesion of invasive
squamous carcinoma, can be classified histologically as CIN grades I to
III. Not all CIN lesions progress to invasive cancer. In fact, most of the
CIN I and II lesions spontaneously regress. However, factors that
determine regression, persistence, or progression of CIN remain unknown.
In this proposed prospective study, women with histopathologically
diagnosed CIN I or II will be enrolled in a 12-month non-therapeutic
follow-up study. The purpose is to identify biomarkers that predict
spontaneous regression and persistence of cervix dysplasia. Defining
biomarkers that modulate the biological process of CIN, the intermediate
endpoint for invasive cancer, will provide valuable information on the
carcinogenesis of cervix cancer. With a 12-month follow-up period, the
emphasis of the study is not on progression, but rather on
regression/persistence of CIN. Gaining insight about regression will have
significant implications for understanding the natural history of the
neoplasm as well as the prognosis and clinical management of women with
CIN I or II.
Women with histopathologically confirmed CIN I or II (N=465) will be
recruited from the Bronx Municipal Hospital and the gynecology clinic of
the Albert Einstein College of Medicine. They will be followed at 3-month
intervals by Pap smear and colposcopy for 12 months. An endpoint biopsy
will be performed at 12 months. The outcome of the study will be the
presence (persistence) or absence (regression) of CIN lesion at 12 months.
At each visit, cervico-vaginal lavage and a cervical swab sample will be
collected for human papillomavirus (HPV) DNA analyses by both southern
blot and polymerase chain reaction (PCR) techniques. Extracted DNA will
also be used for typing of class II HLA-DQB1 and HLA-DRB1 alleles by PCR.
Blood and urine samples as well as questionnaire data will be collected at
baseline, 6, and 12 months. Plasma beta-carotene, ascorbic acid, and
alpha-tocopherol levels will be measured by high pressure liquid
chromatography methods, and red cell folate levels by Radioassay. The
urinary ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone will be
assessed by Enzyme Immunoassay. The questionnaire will collect
information on demographic and behavioral factors. The study pathologist
will review the initial and endpoint biopsy specimens, and the histologic
characteristics of the lesion will be recorded.
The association between regression/persistence of CIN and each of these
biomarkers will first be examined in univariate analyses by chi-square, t
test, and Wilcoxon rank sum test. Whether the outcome of CIN is influenced
by interaction between HPV infection and another co-factor will be
examined in stratification analyses. Finally, significant variables and
interaction terms will be subjected to multiple logistic regression
analysis where independent factors will be identified. ROC curve analysis
will be used to examine the sensitivity and specificity of this model in
discriminating women who will have regression versus women who will have
persistent or progressive CIN.
Publications
Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: managed by watchful waiting.
Authors: Ho G.Y.
, Einstein M.H.
, Romney S.L.
, Kadish A.S.
, Abadi M.
, Mikhail M.
, Basu J.
, Thysen B.
, Reimers L.
, Palan P.R.
, et al.
.
Source: Journal Of Lower Genital Tract Disease, 2011 Oct; 15(4), p. 268-75.
PMID: 21811178
Related Citations
Variability Of Serum Levels Of Tumor Necrosis Factor-alpha, Interleukin 6, And Soluble Interleukin 6 Receptor Over 2 Years In Young Women
Authors: Ho G.Y.
, Xue X.N.
, Burk R.D.
, Kaplan R.C.
, Cornell E.
, Cushman M.
.
Source: Cytokine, 2005-04-07 00:00:00.0; 30(1), p. 1-6.
PMID: 15784406
Related Citations
Polymorphism Of The Insulin Gene Is Associated With Increased Prostate Cancer Risk
Authors: Ho G.Y.
, Melman A.
, Liu S.M.
, Li M.
, Yu H.
, Negassa A.
, Burk R.D.
, Hsing A.W.
, Ghavamian R.
, Chua S.C.
.
Source: British Journal Of Cancer, 2003-01-27 00:00:00.0; 88(2), p. 263-9.
PMID: 12610512
Related Citations
Regression Of Cervical Intraepithelial Neoplasia And Loss Of Human Papillomavirus (hpv) Infection Is Associated With Cell-mediated Immune Responses To An Hpv Type 16 E7 Peptide
Authors: Kadish A.S.
, Timmins P.
, Wang Y.
, Ho G.Y.
, Burk R.D.
, Ketz J.
, He W.
, Romney S.L.
, Johnson A.
, Angeletti R.
, et al.
.
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2002 May; 11(5), p. 483-8.
PMID: 12010863
Related Citations
Transmission/disequilibrium Tests Of Androgen Receptor And Glutathione S-transferase Pi Variants In Prostate Cancer Families
Authors: Ho G.Y.
, Knapp M.
, Freije D.
, Nelson W.G.
, Smith J.R.
, Carpten J.D.
, Bailey-Wilson J.E.
, Beaty T.H.
, Petersen G.
, Xu J.
, et al.
.
Source: International Journal Of Cancer, 2002-04-20 00:00:00.0; 98(6), p. 938-42.
PMID: 11948476
Related Citations
Pcr Detection Of Human Papillomavirus: Comparison Between My09/my11 And Gp5+/gp6+ Primer Systems
Authors: Qu W.
, Jiang G.
, Cruz Y.
, Chang C.J.
, Ho G.Y.
, Klein R.S.
, Burk R.D.
.
Source: Journal Of Clinical Microbiology, 1997 Jun; 35(6), p. 1304-10.
PMID: 9163434
Related Citations